Live feed
Filing
SC 13D
SC 13D0001193125-14-405303·Omega Fund III, L.P.
Schedule 13D ownership disclosure
Transcept Pharmaceuticals Inc
Security class unavailable · CUSIP: 89354M106
Event date: 2014-10-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-14-405303
- Form type
- SC 13D
- Filer
- Omega Fund III, L.P.
- CIK
- CIK 1403748
- Filed
- Nov 10, 2014
- Reporting period
- Oct 30, 2014
- Description
- Schedule 13D beneficial ownership